Evidence map›Paper›PMID 35028656›Full record

Trial reportAnnals of behavioral medicine : a publication of the Society of Behavioral Medicine2022

Moderators of the Effects of mySmartSkin, a Web-Based Intervention to Promote Skin Self-examination and Sun Protection Among Individuals Diagnosed With Melanoma.

Sharon Manne, Carolyn J Heckman, Deborah Kashy, Lee Ritterband, Frances Thorndike, Carolina Lozada, Elliot J Coups

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Sharon ManneDepartment of Medicine, Behavioral Sciences, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.ORCID 0000-0002-9304-7822
Carolyn J HeckmanDepartment of Medicine, Behavioral Sciences, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Deborah KashyMichigan State University, Department of Psychology, East Lansing, MI, USA.
Lee RitterbandSchool of Medicine, Center for Behavioral Health and Technology, University of Virginia, Charlottesville, VA, USA.
Frances ThorndikePear Therapeutics, Boston, MA, USA.
Carolina LozadaDepartment of Medicine, Behavioral Sciences, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Elliot J Coups
Rutgers, The State University of New Jersey · USMichigan State University · USPear Therapeutics (United States) · USUniversity of Virginia · US

Funding

An Internet-Based Behavioral Intervention for Individuals Diagnosed with MelanomaR01CA171666 · NCI · RBHS -CANCER INSTITUTE OF NEW JERSEY · PI MANNE, SHARON L · 2014 to 2018
$2.5M
Biometrics Shared Resource NCI-CCSG P30CA072720-5918CDC HHS NU5U58DP006279-02-00NCI NIH HHS R01 CA171666Surveillance, Epidemiology and End Results HHSN261201300021I
6 · The paper itself

Abstract

backgroundIdentifying the characteristics of persons who benefit more from behavioral interventions can help health care providers decide which individuals should be offered particular interventions because this is the subgroup of persons who are more likely to derive greater benefit from the intervention and refine the underlying constructs of the model guiding the intervention. PURPOSE: This study evaluated possible demographic, medical, knowledge and attitudinal, and psychosocial variables that may moderate the impact of an online intervention, called mySmartSkin (MSS), on engagement in skin self-examination (SSE) and sun protection behaviors among melanoma survivors.

methodsParticipants completed a baseline survey and were then randomized to the MSS condition or usual care. Follow-up surveys were completed by participants at 8-, 24-, and 48-week postrandomization.

resultsA greater impact of MSS on SSE was illustrated among participants with more phenotypic skin cancer risk factors and participants reporting lower baseline self-efficacy in conducting SSE. A more favorable response of MSS on sun protection behaviors was shown when initial knowledge about abnormal lesions and sun protection barriers were high. Greater use of MSS and more favorable evaluations of it were also associated with higher intervention response.

conclusionsFuture studies seeking to improve SSE and sun protection among melanoma survivors might benefit from focusing on survivors who report more skin cancer risk factors, lower self-efficacy in conducting SSE, less knowledge about what abnormal skin lesions look like, more perceived barriers to sun protection behaviors, and less worry about recurrence and cancer-related distress.

Indexed as

Internet-Based InterventionMelanomaSkin NeoplasmsHealth BehaviorHumansSelf-ExaminationSunscreening AgentsSurvivorsSyndromeSunscreening AgentsCancer survivorsDigital interventionsMelanomaModerator effectsSkin self-examinationSun protection

Identifiers

PMID35028656
PMCPMC9345181
OpenAlexW4205783201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.